HomeNewsBusinessAnalysis: GST collections at record high, but wait until January numbers to fit a trend

Analysis: GST collections at record high, but wait until January numbers to fit a trend

Wedding-related spending, year-end vacations despite restrictions and backlog of taxes may have aided December GST collections.

January 02, 2021 / 07:31 IST
Story continues below Advertisement

How do you spot the onset of an economic recovery without poring through reams of numbers that official statisticians put out? The immediate signals are mostly visible in the nearest mall, cars on roads, neighbourhood mom-and-pop shops, restaurants, weekly haats, office complexes, and, of course, sales of intermediates such as cement and steel.

How can you infer that people are buying more goods without measuring footfalls at shops and restaurants? One way of doing that is to track taxes that consumers pay while buying goods and using services.

Story continues below Advertisement

Goods and Services tax (GST) collections that are released monthly allow us to do that. Latest data shows that GST collections touched a record high of Rs 1.15 lakh crore in December, the highest ever since the new tax system kicked-in from July 1, 2017, in a grand midnight event in Parliament. The previous highest was in April 2019 when GST collections stood at Rs 1,13,865 crore.

GST collections topped Rs 1 lakh crore for the third consecutive month in December, which may be a signal of a sustained recovery in the broader economy, aided by greater household spending and brisker business activity.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show